Liu Guanmo, Yang Fan, Gao Lu, Chen Chang, Wei Jiaxin, Zheng Yongchang, Mao Feng
Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Transl Cancer Res. 2023 Jun 30;12(6):1635-1646. doi: 10.21037/tcr-22-2463. Epub 2023 Jun 19.
Breast cancer is the most common malignancy in women, and metastasis to other target organs is one of the main causes of death. Breast cancer liver metastasis (BCLM) has long been a research focus. Enhancing therapeutic effects, optimizing treatment plans and improving the prognosis of patients are major clinical challenges at present.
We performed a comprehensive, nonsystematic review of the latest literature to define the current metastatic mechanism and related treatment advances of BCLM.
Due to the lack of research on the mechanism of BCLM, present treatment programs still have limited benefits, and the prognosis of patients is generally poor. New research directions and treatment ideas for BCLM are urgently needed. In this article, we indicated the specific procedures of the BCLM mechanism from the microenvironment to metastasis formation and progress in treatment, including drug therapies such as targeted therapy, surgery, intervention therapy and radiotherapy. Research on the molecular mechanism plays a crucial role in the development of BCLM-related therapies. Based on the metastasis process, we are able to propel new findings and further progression of antineoplastic drugs.
The process of BCLM is multistep, and various factors are involved in it, which provides a powerful theoretical basis for the development of therapeutic methods for treatment of this disease. Further understanding of the mechanism of BCLM is essential to guide clinical management.
乳腺癌是女性最常见的恶性肿瘤,转移至其他靶器官是主要死亡原因之一。乳腺癌肝转移(BCLM)长期以来一直是研究热点。提高治疗效果、优化治疗方案以及改善患者预后是目前主要的临床挑战。
我们对最新文献进行了全面的非系统性综述,以明确BCLM目前的转移机制及相关治疗进展。
由于对BCLM机制缺乏研究,目前的治疗方案获益仍然有限,患者预后普遍较差。迫切需要BCLM新的研究方向和治疗思路。在本文中,我们阐述了从微环境到转移形成的BCLM机制的具体过程以及治疗进展,包括靶向治疗、手术、介入治疗和放疗等药物治疗。分子机制研究在BCLM相关治疗的发展中起着关键作用。基于转移过程,我们能够推动抗肿瘤药物的新发现和进一步发展。
BCLM过程是多步骤的,涉及多种因素,这为开发该疾病的治疗方法提供了有力的理论依据。进一步了解BCLM机制对于指导临床管理至关重要。